European Urology Focus

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

European Urology Focus is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,800 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
2405-4569
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
3,800 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2017-01-01
  • PUBMED · 2016-12-15
Indexing
MEDLINE · PUBMED
APC
3,800 USD
Declared review time (DOAJ)
—
Actual review time (measured)
64 days received→accepted — computed from PubMed (n=98)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2268

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

79

i10-index

1034

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
94%
ORCID iDs in current deposits
46%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101665661
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Urinary Bladder and Prostate Research
  • Urinary Bladder and Prostate Research
Show all subjects (50)
  • Renal cell carcinoma treatment
  • Renal cell carcinoma treatment
  • Pelvic floor disorders treatments
  • Pelvic floor disorders treatments
  • Urinary and Genital Oncology Studies
  • Urinary and Genital Oncology Studies
  • Urinary Tract Infections Management
  • Urinary Tract Infections Management
  • Urological Disorders and Treatments
  • Urological Disorders and Treatments
  • Kidney Stones and Urolithiasis Treatments
  • Kidney Stones and Urolithiasis Treatments
  • Pediatric Urology and Nephrology Studies
  • Pediatric Urology and Nephrology Studies
  • Sexual function and dysfunction studies
  • Sexual function and dysfunction studies
  • Ureteral procedures and complications
  • Ureteral procedures and complications
  • Urologic and reproductive health conditions
  • Urologic and reproductive health conditions
  • Hormonal and reproductive studies
  • Hormonal and reproductive studies
  • Renal and related cancers
  • Renal and related cancers
  • Genital Health and Disease
  • Genital Health and Disease
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Surgical Simulation and Training
  • Surgical Simulation and Training
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: